Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status

Area of Science:

• Public Health
• Vaccinology
• Global Health Initiatives

Background:

• Vaccination is crucial for public health but faces challenges like cost, access, and R&D.
• Developing countries grapple with specific hurdles in vaccine provision and manufacturing.
• Global efforts are underway to address these persistent gaps in vaccine-preventable disease control.

Purpose of the Study:

• To provide an overview of the Developing Country Vaccine Manufacturers' Network (DCVMN).
• To examine the origin, objectives, achievements, and limitations of DCVMN.
• To discuss future expectations for DCVMN in global vaccine manufacturing.

Main Methods:

• Review of the establishment and evolution of the DCVMN.
• Analysis of DCVMN's role in facilitating vaccine production and distribution.
• Examination of case studies and reports related to DCVMN's impact.

Main Results:

• DCVMN has emerged as a significant international body for vaccine manufacturers in developing nations.
• The network plays a key role in enabling the production of affordable, quality vaccines.
• DCVMN contributes to addressing unmet public health needs in vaccine-preventable diseases.

Conclusions:

• DCVMN is a vital initiative by developing countries to enhance global vaccine equity.
• The network's achievements highlight the potential for South-South collaboration in health.
• Continued support and strategic development are crucial for DCVMN's future success.